Right ventricular dysfunction, late gadolinium enhancement, and female gender predict poor outcome in patients with

Christina Doesch1, Désirée-Marie Dierks2, Dariusch Haghi1

  • 11st Department of Medicine, Cardiology, University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research) partner site, Mannheim, Germany.

Insights

Cardiovascular magnetic resonance imaging (CMR) parameters, including late gadolinium enhancement (LGE) and right ventricular ejection fraction (RV-EF), offer crucial prognostic insights in dilated cardiomyopathy (DCM) patients, surpassing traditional left ventricular function assessments.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Biomarkers

Background:

  • Dilated cardiomyopathy (DCM) presents a variable clinical course with substantial morbidity and mortality.
  • Current risk stratification primarily relies on left ventricular function (LVF), which has limited individual outcome prediction.
  • Novel imaging biomarkers are needed for more accurate prognostication in DCM.

Purpose of the Study:

  • To investigate the prognostic value of cardiovascular magnetic resonance imaging (CMR) parameters, specifically late gadolinium enhancement (LGE) and epicardial adipose tissue (EAT).
  • To assess the utility of these CMR findings in predicting outcomes in patients with DCM.
  • To compare the prognostic performance of CMR parameters against traditional LVF measures.

Main Methods:

  • A cohort of 140 DCM patients underwent LGE-CMR.
  • Median follow-up was 3 years, with assessment of all-cause mortality and hospitalization for congestive heart failure (CHF).
  • Multivariable analysis was employed to identify independent predictors of adverse outcomes.

Main Results:

  • Female gender and right ventricular ejection fraction (RV-EF) below 38% independently predicted all-cause mortality.
  • RV-EF below 38% was the sole independent predictor for CHF hospitalization.
  • Patients who died showed a higher prevalence of LGE and reduced EAT compared to those hospitalized for CHF.

Conclusions:

  • Female gender, RV-EF, and the presence of LGE are significant prognostic indicators in DCM.
  • CMR is a valuable tool for enhancing risk stratification in DCM patients.
  • These findings support the integration of CMR-derived parameters into clinical decision-making for DCM management.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
766
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
789
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
930
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.1K